Study of LC23-1306 in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

113

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

November 30, 2012

Study Completion Date

August 31, 2013

Conditions

Acute Coronary Syndrome

Interventions

DRUG

LC23-1306

LC23-1306 10, 30, 100, 200, 400, 600 mg Placebo 10, 30, 100, 200, 400, 600 mg

DRUG

placebo

LC23-1306 placebo

DRUG

Ticagrelor

Ticagrelor 90mg

Trial Locations (1)

Seoul National University Hospital, Seoul